Aktualios biotechnologijos, UAB - financials and debts

Company age: 10 y. 6 mo.

Update

A Bankroto case has been opened against the company!

Process status: Active
Court: Kauno apygardos teismas
Case No.: eB2-743-1043/2025
Date of ruling: 2025-03-04

Aktualios biotechnologijos - Company finances

  • The company has not submitted financial data for these years: 2024.
EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 2,652 - - - - 75,471 -
Profit before tax - - - - -57,164 39,519 -2,595
Net profit -30,628 -18,029 -44,716 -69,010 -57,164 39,519 -2,595
Equity -33,234 -51,263 -95,979 -164,990 -222,154 -182,635 59,860
Liabilities 37,663 273,889 282,321 286,376 306,101 280,980 17,720
Non-current assets 0 187,360 95,157 70,817 46,477 22,137 0
Current assets 4,429 36,952 91,185 50,569 37,470 83,953 77,580
Total assets 4,429 224,312 186,342 121,386 83,947 106,090 77,580
Taxes paid
STI taxes - - - - - 1,683 -
Financial indicators
Revenue change y/y - - - - - - -
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -691.5% -8.0% -24.0% -56.9% -68.1% 37.3% -3.3%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - - - - - - -4.3%
Profit margin Net profit margin. Shows the overall profitability of the company. -1154.9% - - - - 52.4% -
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - - - - - 52.4% -
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - - - - - 0.3
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 1,326 - - - - 75,471 -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Aktualios biotechnologijos - Social security debts

From To Debt, €
2023-11-17 2023-12-05 181.75
2023-11-07 2023-11-16 308.59
2023-10-31 2023-11-06 36.34
2023-10-26 2023-10-30 41.38
2023-10-20 2023-10-25 313.63
2023-10-17 2023-10-19 41.38
2023-09-18 2023-10-16 35.00
2023-08-17 2023-09-17 24.36
2023-07-28 2023-08-16 13.72
2023-07-26 2023-07-27 10.64
2023-07-24 2023-07-25 13.81
2023-07-18 2023-07-23 10.64
2023-06-16 2023-06-27 256.31
2023-05-16 2023-06-13 338.74
2023-05-04 2023-05-15 122.91
2023-05-02 2023-05-03 148.41
2023-04-26 2023-04-28 148.41
2023-04-18 2023-04-25 147.06
2023-02-17 2023-02-27 314.73
2023-02-07 2023-02-16 93.38
2023-02-06 2023-02-06 174.00
2023-01-24 2023-02-03 174.00
2023-01-17 2023-01-23 170.87
2022-12-28 2022-12-28 31.79
2022-12-16 2022-12-27 153.79
2022-11-21 2022-11-28 449.13
2022-11-17 2022-11-18 449.13
2022-10-28 2022-11-16 266.06
2022-10-18 2022-10-27 256.31
2022-09-16 2022-09-26 760.16
2022-08-23 2022-09-15 515.51
2022-07-25 2022-08-22 464.24
2022-07-18 2022-07-24 462.62
2022-06-30 2022-07-17 206.31
2022-06-16 2022-06-29 256.31
2022-05-17 2022-05-29 179.80

Aktualios biotechnologijos - VMI tax arrears

From To Overdue, €
2025-02-18 2025-02-27 1121.6
2025-02-06 2025-02-17 33611.28
2025-02-02 2025-02-05 33581.98
2025-01-01 2025-02-01 33340.89
2024-12-03 2024-12-31 33071.5
2024-11-21 2024-12-02 32984.6
2024-11-01 2024-11-20 32810.8
2024-10-01 2024-10-31 21654.51

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.